CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 103 enrolled
Drug / intervention
Electrode-based Sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01400880
NCT01400880Early Ph 1Completed
CompareCT.gov

Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability

Convergent Engineering, Inc.·interventional·Posted Jul 22, 2011·Updated Apr 7, 2026

In Brief

A Early Phase 1 clinical trial evaluating Electrode-based Sensor for Pregnancy. Completed, enrolled 103 participants across 1 site.

Detailed Summary

The specific goal of the proposed research is to develop a reliable, non-invasive fetal and maternal heart rate and contraction monitor that is unaffected by obesity and requires less nursing intervention than the tocodynamometer and Doppler ultrasound.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJul 22, 2011
Enrollment StartJul 1, 2011
Primary CompletionApr 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 14.9 years ago

Interventions

Electrode-based Sensordevice

Electrode-based Sensor for Non-invasive Fetal Heart Rate and EMG Monitoring With Improved Reliability